APA

Molina D., Pérez-Beteta J., Martínez-González A., Sepúlveda J. M., Peralta S., Gil-Gil M. J., Reynes G., Herrero A., De Las Peñas R., Luque R., Capellades J., Balaña C. & Pérez-García V. M. (20170726). Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients. : PloS one.

Chicago

Molina David, Pérez-Beteta Julián, Martínez-González Alicia, Sepúlveda Juan M, Peralta Sergi, Gil-Gil Miguel J, Reynes Gaspar, Herrero Ana, De Las Peñas Ramón, Luque Raquel, Capellades Jaume, Balaña Carmen and Pérez-García Víctor M. 20170726. Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients. : PloS one.

Harvard

Molina D., Pérez-Beteta J., Martínez-González A., Sepúlveda J. M., Peralta S., Gil-Gil M. J., Reynes G., Herrero A., De Las Peñas R., Luque R., Capellades J., Balaña C. and Pérez-García V. M. (20170726). Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients. : PloS one.

MLA

Molina David, Pérez-Beteta Julián, Martínez-González Alicia, Sepúlveda Juan M, Peralta Sergi, Gil-Gil Miguel J, Reynes Gaspar, Herrero Ana, De Las Peñas Ramón, Luque Raquel, Capellades Jaume, Balaña Carmen and Pérez-García Víctor M. Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients. : PloS one. 20170726.